Clinical trial
Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib in Maintenance After Platine-based Chemotherapy for Patients with Ovarian Cancer Late Relapse : the French GINECO - NiQoLe Study
NCT03752216 is registered in ClinicalTrials.gov with ARCAGY/ GINECO GROUP as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib in Maintenance After Platine-based Chemotherapy for Patients with Ovarian Cancer Late Relapse : the French GINECO - NiQoLe Study
- Lead sponsor
- ARCAGY/ GINECO GROUP
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 3, 2019
- Completion date
- December 13, 2022
- Enrollment
- 141 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer